| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.04e-05 | 31 | 105 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 9.72e-05 | 140 | 105 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.09e-04 | 18 | 105 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.47e-04 | 151 | 105 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 5.49e-04 | 193 | 105 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.00e-04 | 129 | 105 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 6.12e-04 | 197 | 105 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 6.87e-04 | 33 | 105 | 3 | GO:0005217 | |
| GeneOntologyBiologicalProcess | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration | 2.57e-05 | 2 | 105 | 2 | GO:0021816 | |
| GeneOntologyBiologicalProcess | manganese ion transmembrane transport | 2.73e-05 | 12 | 105 | 3 | GO:0071421 | |
| GeneOntologyBiologicalProcess | manganese ion transport | 4.48e-05 | 14 | 105 | 3 | GO:0006828 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 4.48e-05 | 14 | 105 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | actin filament-based process | TNIK ROCK2 IQSEC3 ANXA1 TRPM2 SRGAP2 NEB RYR2 TWF1 SPTBN4 SHROOM4 MYH14 NKX2-5 AKAP13 PDCD10 | 5.81e-05 | 912 | 105 | 15 | GO:0030029 |
| GeneOntologyCellularComponent | postsynaptic density | 4.51e-04 | 451 | 105 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | postsynapse | DOCK1 TNIK ROCK2 IQSEC3 RPS3A SRGAP2 GRIN2A CHRM3 PTN SNX14 SLC8A1 BMPR2 PTPRZ1 PLCB3 | 5.68e-04 | 1018 | 105 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | actin cytoskeleton | KNTC1 ANXA1 NEB TWF1 SPTBN4 SHROOM4 MYH14 SCNN1A AKAP13 CROCC | 6.45e-04 | 576 | 105 | 10 | GO:0015629 |
| GeneOntologyCellularComponent | asymmetric synapse | 6.74e-04 | 477 | 105 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | mast cell granule | 6.86e-04 | 8 | 105 | 2 | GO:0042629 | |
| GeneOntologyCellularComponent | early endosome membrane | 7.09e-04 | 212 | 105 | 6 | GO:0031901 | |
| GeneOntologyCellularComponent | supramolecular fiber | KNTC1 DCDC2C ANXA1 RIBC1 NEB RYR2 TWF1 SPTBN4 SHROOM4 SLC8A1 MYH14 ASPM NINL AKAP13 CFAP53 | 7.97e-04 | 1179 | 105 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KNTC1 DCDC2C ANXA1 RIBC1 NEB RYR2 TWF1 SPTBN4 SHROOM4 SLC8A1 MYH14 ASPM NINL AKAP13 CFAP53 | 8.54e-04 | 1187 | 105 | 15 | GO:0099081 |
| GeneOntologyCellularComponent | actin filament | 8.56e-04 | 146 | 105 | 5 | GO:0005884 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 9.80e-04 | 503 | 105 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.25e-03 | 93 | 105 | 4 | GO:0030864 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.29e-03 | 523 | 105 | 9 | GO:0098984 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 MIA3 POLR1A NEIL1 TRPM2 RNF213 SRGAP2 TBL1XR1 CHRM3 SPTBN4 NCOR2 ATF6 BMPR2 MYH14 SCNN1A AKAP13 ZFHX3 TNFAIP8 GNAZ CROCC TMEM63A | 3.90e-09 | 1489 | 106 | 21 | 28611215 |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 5.06e-08 | 168 | 106 | 8 | 30631154 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ROCK2 MIA3 RNF213 GOLM1 SEC22B CACHD1 HMOX2 ATP9A DMXL1 TPCN1 ATF6 SNX14 BMPR2 TRIM28 MANEAL SCARB2 EMC2 | 1.36e-07 | 1201 | 106 | 17 | 35696571 |
| Pubmed | ROCK2 IQSEC3 ANXA1 RPS3A SRGAP2 GRIN2A ATP9A PTGS2 TWF1 SPTBN4 MYH14 TRIM28 PTPRZ1 CDC5L GNAZ CROCC | 6.97e-06 | 1431 | 106 | 16 | 37142655 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 7.47e-06 | 232 | 106 | 7 | 25515538 | |
| Pubmed | TNIK ROCK2 IQSEC3 MIA3 CHD8 SRGAP2 GRIN2A TBL1XR1 TWF1 SPTBN4 NCOR2 TRIM28 CDC5L | 7.68e-06 | 963 | 106 | 13 | 28671696 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ROCK2 KNTC1 ABCF3 RPS3A OGFR THUMPD1 CC2D1B TBL1XR1 TWF1 MYH14 TRIM28 COPS7B PLCB3 TNFAIP8 CROCC PDCD10 | 8.57e-06 | 1455 | 106 | 16 | 22863883 |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22726658 | ||
| Pubmed | Annexin A1 modulates macula densa function by inhibiting cyclooxygenase 2. | 9.20e-06 | 2 | 106 | 2 | 22791338 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27373832 | ||
| Pubmed | Role of salt‑inducible kinase 2 in the malignant behavior and glycolysis of colorectal cancer cells. | 9.20e-06 | 2 | 106 | 2 | 34558647 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28803844 | ||
| Pubmed | Role of annexin 1 gene expression in mouse craniofacial bone development. | 9.20e-06 | 2 | 106 | 2 | 17405164 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19058221 | ||
| Pubmed | Differential induction of glioblastoma migration and growth by two forms of pleiotrophin. | 9.20e-06 | 2 | 106 | 2 | 15908427 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15033764 | ||
| Pubmed | Protein tyrosine phosphatase receptor type Z is inactivated by ligand-induced oligomerization. | 9.20e-06 | 2 | 106 | 2 | 16814777 | |
| Pubmed | Pleiotrophin enhances clonal growth and long-term expansion of human embryonic stem cells. | 9.20e-06 | 2 | 106 | 2 | 17823238 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17727841 | ||
| Pubmed | Cardiac ryanodine receptors control heart rate and rhythmicity in adult mice. | 9.20e-06 | 2 | 106 | 2 | 22869620 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 35354047 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23084748 | ||
| Pubmed | Genome-wide analysis of KAP1 binding suggests autoregulation of KRAB-ZNFs. | 9.20e-06 | 2 | 106 | 2 | 17542650 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28569747 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26644413 | ||
| Pubmed | A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ. | 9.20e-06 | 2 | 106 | 2 | 20738847 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29254791 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22456474 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23192947 | ||
| Pubmed | M3 muscarinic receptor interaction with phospholipase C β3 determines its signaling efficiency. | 9.20e-06 | 2 | 106 | 2 | 24596086 | |
| Pubmed | Characterization of heparin affin regulatory peptide signaling in human endothelial cells. | 9.20e-06 | 2 | 106 | 2 | 15797857 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23678000 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24743769 | ||
| Pubmed | TBLR1 regulates the expression of nuclear hormone receptor co-repressors. | 9.20e-06 | 2 | 106 | 2 | 16893456 | |
| Pubmed | Pleiotrophin mediates hematopoietic regeneration via activation of RAS. | 9.20e-06 | 2 | 106 | 2 | 25250571 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27621312 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26261584 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 1.81e-05 | 17 | 106 | 3 | 27725084 | |
| Pubmed | Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. | 2.57e-05 | 19 | 106 | 3 | 18316483 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 22559944 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 20071776 | ||
| Pubmed | Functional relevance of the stretch-dependent slow force response in failing human myocardium. | 2.76e-05 | 3 | 106 | 2 | 15105296 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23777859 | ||
| Pubmed | Upregulation of fibronectin expression by COX-2 is mediated by interaction with ELMO1. | 2.76e-05 | 3 | 106 | 2 | 20732417 | |
| Pubmed | Cell competition promotes phenotypically silent cardiomyocyte replacement in the mammalian heart. | 2.76e-05 | 3 | 106 | 2 | 25199831 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 16678093 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30497491 | ||
| Pubmed | Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function. | 2.76e-05 | 3 | 106 | 2 | 19376970 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30848941 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24812305 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19749796 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17681947 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 37966164 | ||
| Pubmed | The prognostic significance of annexin A family in glioblastoma. | 2.76e-05 | 3 | 106 | 2 | 34398393 | |
| Pubmed | MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. | 2.76e-05 | 3 | 106 | 2 | 20339119 | |
| Pubmed | 4.66e-05 | 23 | 106 | 3 | 26321200 | ||
| Pubmed | Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication. | 5.50e-05 | 4 | 106 | 2 | 22559943 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 10706604 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 27445335 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 17368428 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 26334248 | ||
| Pubmed | An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart. | 5.50e-05 | 4 | 106 | 2 | 23436819 | |
| Pubmed | Mitochondrial fusion is essential for organelle function and cardiac homeostasis. | 5.50e-05 | 4 | 106 | 2 | 22052916 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 30667096 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 23031429 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 28855648 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 6.71e-05 | 444 | 106 | 8 | 34795231 | |
| Pubmed | Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome. | 7.63e-05 | 27 | 106 | 3 | 18468998 | |
| Pubmed | 7.96e-05 | 74 | 106 | 4 | 17255364 | ||
| Pubmed | 8.39e-05 | 339 | 106 | 7 | 37232246 | ||
| Pubmed | TNIK KNTC1 MIA3 POLR1A RNF213 SRGAP2 HMOX2 AKAP13 CDC5L CROCC | 8.41e-05 | 733 | 106 | 10 | 34672954 | |
| Pubmed | 8.53e-05 | 28 | 106 | 3 | 25332179 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 25193470 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 9507007 | ||
| Pubmed | Order of six loci at 2q24-q31 and orientation of the HOXD locus. | 9.15e-05 | 5 | 106 | 2 | 7896287 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 23071553 | ||
| Pubmed | Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration. | 9.15e-05 | 5 | 106 | 2 | 29651006 | |
| Pubmed | Genome-Nuclear Lamina Interactions Regulate Cardiac Stem Cell Lineage Restriction. | 9.15e-05 | 5 | 106 | 2 | 29033129 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 22355118 | ||
| Pubmed | 9.35e-05 | 148 | 106 | 5 | 22898364 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | TNIK CCDC137 DCDC2C CC2D1B SEC22B GRIN2A TWF1 CASP12 MYH14 MANEAL ASPM NINL CFAP53 | 1.06e-04 | 1242 | 106 | 13 | 30973865 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.07e-04 | 475 | 106 | 8 | 31040226 | |
| Pubmed | 1.20e-04 | 156 | 106 | 5 | 32850835 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 19549818 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 9405631 | ||
| Pubmed | Arl13b and the exocyst interact synergistically in ciliogenesis. | 1.37e-04 | 6 | 106 | 2 | 26582389 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 17098867 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 19141530 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 23540699 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 25644401 | ||
| Pubmed | 1.38e-04 | 493 | 106 | 8 | 15368895 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MIA3 POLR1A GOLM1 SEC22B CACHD1 HMOX2 ATP9A EXOC8 ATF6 EMC2 STX7 | 1.45e-04 | 942 | 106 | 11 | 31073040 |
| Pubmed | 1.60e-04 | 504 | 106 | 8 | 34432599 | ||
| Pubmed | TNIK MIA3 RPS3A SEC22B HMOX2 DMXL1 ATF6 EXOC5 ASPM SIK2 AKAP13 CDC5L EMC2 STX7 | 1.72e-04 | 1487 | 106 | 14 | 33957083 | |
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 24255096 | ||
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 15695367 | ||
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 12781968 | ||
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | 2.05e-04 | 392 | 106 | 7 | 33144569 | |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 2.52e-04 | 183 | 106 | 5 | 31932471 | |
| Pubmed | beta-Catenin is a Nek2 substrate involved in centrosome separation. | 2.55e-04 | 8 | 106 | 2 | 18086858 | |
| GeneFamily | Exocyst complex | 5.23e-04 | 9 | 70 | 2 | 1055 | |
| GeneFamily | Annexins|Endogenous ligands | 1.12e-03 | 13 | 70 | 2 | 404 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | RPS3A CACHD1 ATP9A VSIR TPCN1 MMRN1 IER5L DPEP3 SCNN1A CCDC68 ZFHX3 ANKRD18A ALPK2 | 8.36e-06 | 740 | 105 | 13 | M41202 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | TNIK IQSEC3 ANXA1 TTC39C RNF213 CACHD1 SPTBN4 SLC8A1 BMPR2 MYH14 AKAP13 TNFAIP8 PCYT1B TMEM63A | 1.09e-05 | 726 | 103 | 14 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.81e-05 | 233 | 103 | 8 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.58e-06 | 151 | 105 | 6 | 2470162f4b56bc505db166a6eb0fa54847759df8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.96e-06 | 184 | 105 | 6 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.28e-06 | 186 | 105 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 5.44e-06 | 187 | 105 | 6 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | ASK452-Immune-Mast_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.61e-06 | 188 | 105 | 6 | 840215e16cff90f821f776186284eafcf2350690 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 5.61e-06 | 188 | 105 | 6 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | mild-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.06e-06 | 109 | 105 | 5 | 2f03d6ee8b13424cc6a5bc60ac3461b44dff9d79 | |
| ToppCell | ASK452-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.33e-06 | 192 | 105 | 6 | 8269b88ff6073a908f547fcc7c5941f2e8289694 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-06 | 195 | 105 | 6 | 5812b1615676f3b77eb4769216b98b360c417c0d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-06 | 197 | 105 | 6 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.33e-06 | 197 | 105 | 6 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.55e-06 | 198 | 105 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.55e-06 | 198 | 105 | 6 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | critical-Epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.77e-06 | 199 | 105 | 6 | bbb44e2a52f102a6d891ead6c06d6c07221abd33 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.77e-06 | 199 | 105 | 6 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.77e-06 | 199 | 105 | 6 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | NS-critical-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.77e-06 | 199 | 105 | 6 | 3b68197ec01c5f2b315d9e9b6eb02d5f6b5b77a3 | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.99e-06 | 200 | 105 | 6 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.99e-06 | 200 | 105 | 6 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | 5'-Airway_Nasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.99e-06 | 200 | 105 | 6 | f6e967738b4f7b173d6e9977e305f77380dd6c8a | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 133853d0f55c63ebe94dd54151f9f1f90650a0d8 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | 5'-Airway_Nasal-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.99e-06 | 200 | 105 | 6 | 358d71329921451c7f5a56f1db0f9989af2299dc | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 143 | 105 | 5 | 7adc34d8ad11e57950a5a258ae9bf8f52259385a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-05 | 144 | 105 | 5 | 1efa434e577d1f87e02df01667782f414d63bd60 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-05 | 144 | 105 | 5 | c0c5f254a960ba5e5f1354599d54e77360e6c2ac | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage-B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.03e-05 | 152 | 105 | 5 | 5ce8920aedd39a4daf7082153b5e213707c14227 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|World / disease group, cell group and cell class (v2) | 3.13e-05 | 153 | 105 | 5 | aff5c8ab1fb4ebc324cec02cf562b7484bb10db8 | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 3.87e-05 | 160 | 105 | 5 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.87e-05 | 160 | 105 | 5 | 5cd4fbbd2ce671a8377416eff94041a111375dee | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 3.99e-05 | 161 | 105 | 5 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | Control-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 4.11e-05 | 162 | 105 | 5 | e3b9b46ce2faff7d099502df14bbf51e9f183f8c | |
| ToppCell | Control-Epithelial-Ionocyte|Control / Disease state, Lineage and Cell class | 4.23e-05 | 163 | 105 | 5 | bf09fa39bf3e6b3a776d5e79c30c96df572956a3 | |
| ToppCell | mild-immature_Neutrophil|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.47e-05 | 83 | 105 | 4 | f7225bc24ad6df3a41375cc4614af824e0db3559 | |
| ToppCell | severe-HSPC|severe / disease stage, cell group and cell class | 4.48e-05 | 165 | 105 | 5 | acd837d88ad3786c263f74651a6c0e02fa2fa2c5 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.75e-05 | 167 | 105 | 5 | 99db8871c62336bd215efb65e969783d2b6003b0 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.88e-05 | 168 | 105 | 5 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 4.88e-05 | 168 | 105 | 5 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.88e-05 | 168 | 105 | 5 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.02e-05 | 169 | 105 | 5 | e9c0e0f4c421c7bdbf1a7e33002f3cf22ea307cb | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.02e-05 | 169 | 105 | 5 | d375a1df1ecc938f66bad92e54b8cda26ca9c472 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.02e-05 | 169 | 105 | 5 | 58f805c0be507bd5fadc9ea3555032daabbc8ab8 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 170 | 105 | 5 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.26e-05 | 177 | 105 | 5 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.26e-05 | 177 | 105 | 5 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-05 | 178 | 105 | 5 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 179 | 105 | 5 | 30efe1f0394c0edb27b91890b5c4637b73cbc5ec | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.60e-05 | 179 | 105 | 5 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | LA-06._Ventricular_Cardiomyocyte_II|LA / Chamber and Cluster_Paper | 6.68e-05 | 92 | 105 | 4 | fad2e02ae858e3a9bbe51ad1c689f7e31d11ce0e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-05 | 180 | 105 | 5 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.95e-05 | 181 | 105 | 5 | 3dcb74b28f93be35ddf4de1937f7e30b25e11927 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.95e-05 | 181 | 105 | 5 | 7679a5980011d6dfb1aaca7abf678c29b6f819bb | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.14e-05 | 182 | 105 | 5 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 182 | 105 | 5 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.14e-05 | 182 | 105 | 5 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.14e-05 | 182 | 105 | 5 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.14e-05 | 182 | 105 | 5 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.32e-05 | 183 | 105 | 5 | ab38264daddccdf5ffb75ff2210b27423eca6bc0 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.32e-05 | 183 | 105 | 5 | e4911601dca2c0ecb448cdb6b222dedfc0c8bf6c | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.32e-05 | 183 | 105 | 5 | 263bfa1d8a7314bc3156c735c403c3bab8ea4dac | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 7.51e-05 | 184 | 105 | 5 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-05 | 184 | 105 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.91e-05 | 186 | 105 | 5 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.91e-05 | 186 | 105 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-05 | 187 | 105 | 5 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-05 | 187 | 105 | 5 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 8.11e-05 | 187 | 105 | 5 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-05 | 187 | 105 | 5 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.32e-05 | 188 | 105 | 5 | c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.53e-05 | 189 | 105 | 5 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.74e-05 | 190 | 105 | 5 | 1307688255a1250fa300edf2c41f1affe31dcc98 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.74e-05 | 190 | 105 | 5 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.74e-05 | 190 | 105 | 5 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.74e-05 | 190 | 105 | 5 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 8.74e-05 | 190 | 105 | 5 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.74e-05 | 190 | 105 | 5 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.96e-05 | 191 | 105 | 5 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.96e-05 | 191 | 105 | 5 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 191 | 105 | 5 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.96e-05 | 191 | 105 | 5 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 191 | 105 | 5 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.96e-05 | 191 | 105 | 5 | e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.18e-05 | 192 | 105 | 5 | b877d14be9d04ab0010e340909e3a23de92613db | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-05 | 192 | 105 | 5 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-05 | 192 | 105 | 5 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.41e-05 | 193 | 105 | 5 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 9.41e-05 | 193 | 105 | 5 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 9.41e-05 | 193 | 105 | 5 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 9.64e-05 | 194 | 105 | 5 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.64e-05 | 194 | 105 | 5 | bde6830a281f7cd7fd1733e40a41ddd2673ba88e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 195 | 105 | 5 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | Nasal_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.87e-05 | 195 | 105 | 5 | 7509b980b6b293df02bec619ef5b83a6c7b49c03 | |
| ToppCell | IIF-Lymphocyte-T_NK-CD4_TCM|IIF / Disease, Lineage and Cell Type | 9.87e-05 | 195 | 105 | 5 | 8f5d469ef00132637154f6e8847ba4d1e4f008cb | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.87e-05 | 195 | 105 | 5 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.87e-05 | 195 | 105 | 5 | 3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 195 | 105 | 5 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | distal-Hematologic-Basophil/Mast_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.87e-05 | 195 | 105 | 5 | 4f83449fce3717518e2acbba1a4b3bea765c0bdb | |
| ToppCell | 3'-Airway_Nasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.87e-05 | 195 | 105 | 5 | 7ffbdbe95b248699bf6300322d084d21a4a4b1b8 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.87e-05 | 195 | 105 | 5 | 22191d361af136942508f1553ff41a626ed982ad | |
| Disease | heart septal defect (is_implicated_in) | 7.21e-05 | 4 | 103 | 2 | DOID:1681 (is_implicated_in) | |
| Disease | brain ischemia (implicated_via_orthology) | 2.49e-04 | 35 | 103 | 3 | DOID:2316 (implicated_via_orthology) | |
| Disease | brain ischemia (biomarker_via_orthology) | 4.58e-04 | 102 | 103 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Proteinuria | 4.61e-04 | 43 | 103 | 3 | C0033687 | |
| Disease | glioblastoma (is_marker_for) | 4.93e-04 | 44 | 103 | 3 | DOID:3068 (is_marker_for) | |
| Disease | dry eye syndrome (is_marker_for) | 5.33e-04 | 10 | 103 | 2 | DOID:10140 (is_marker_for) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 6.50e-04 | 11 | 103 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Cognitive impairment | 6.50e-04 | 11 | 103 | 2 | HP_0100543 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 7.19e-04 | 50 | 103 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | esophagus adenocarcinoma (is_marker_for) | 7.78e-04 | 12 | 103 | 2 | DOID:4914 (is_marker_for) | |
| Disease | Acute Cerebrovascular Accidents | 9.00e-04 | 54 | 103 | 3 | C0751956 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 9.18e-04 | 13 | 103 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | pleurisy (implicated_via_orthology) | 9.18e-04 | 13 | 103 | 2 | DOID:10247 (implicated_via_orthology) | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 1.07e-03 | 14 | 103 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 1.07e-03 | 14 | 103 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | Cerebrovascular accident | 1.35e-03 | 62 | 103 | 3 | C0038454 | |
| Disease | pulmonary fibrosis (is_implicated_in) | 1.40e-03 | 16 | 103 | 2 | DOID:3770 (is_implicated_in) | |
| Disease | high altitude adaptation | 1.59e-03 | 17 | 103 | 2 | EFO_0009105 | |
| Disease | Malignant Glioma | 1.91e-03 | 70 | 103 | 3 | C0555198 | |
| Disease | mixed gliomas | 1.91e-03 | 70 | 103 | 3 | C0259783 | |
| Disease | pulmonary non-tuberculous mycobacterial infection | 1.99e-03 | 19 | 103 | 2 | MONDO_0018469 | |
| Disease | diet measurement, body mass index | 2.20e-03 | 20 | 103 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | Autistic Disorder | 2.26e-03 | 261 | 103 | 5 | C0004352 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 3.17e-03 | 24 | 103 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 3.32e-03 | 85 | 103 | 3 | C1510586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERAVQAYRALKQRQQ | 256 | Q6PK04 | |
| KNRNQLREYQLEGVN | 806 | Q9HCK8 | |
| NYQALDADFRKLRQQ | 231 | Q99459 | |
| NKSYQQLRLVFQEFQ | 201 | Q9UJ72 | |
| RYSQQLNDLKAENAR | 386 | Q8IVF6 | |
| QVLRANQYKENHNRT | 191 | Q9H9Q2 | |
| NAIKQLNNYEIRNGR | 111 | Q9NQ94 | |
| NNDELIQRNYKLAAQ | 1966 | Q86TB3 | |
| RNQSSENKRQLANYN | 136 | O95870 | |
| LNQQREYEAQQQYRQ | 421 | Q9NUQ8 | |
| IDRFRYNANRASQVQ | 441 | Q9NUQ8 | |
| QQYQQRQSVIFHKRA | 571 | P20309 | |
| RQDLANLQKQQAQYL | 2581 | Q12802 | |
| FNRYLDVVNRNKQVV | 96 | Q5VU97 | |
| FQQSRRAAVLIQQHY | 1121 | O94983 | |
| SQQSIFNRYAQQRLD | 501 | Q6MZZ7 | |
| FNRYAQQRLDIDATQ | 506 | Q6MZZ7 | |
| YLRDQQRNQTNTFFG | 636 | P18850 | |
| QALNRRFQQTQYLAL | 141 | P56177 | |
| ALRNVAQRLFENYQT | 126 | Q9H2F9 | |
| LNIRNKEFNYLHNRN | 101 | Q6UXS9 | |
| YVFDLCQRQQRQLFQ | 2911 | Q9Y485 | |
| QQYQANRAAKLQRQH | 2366 | Q8IZT6 | |
| KNRKVYRQQQNSNIF | 46 | L0R819 | |
| YRQQQNSNIFFLADR | 51 | L0R819 | |
| FNRKARQENLRYNNM | 1746 | Q6ZS30 | |
| MQAQQYQQQRRKFAA | 1 | P21246 | |
| KRNNAQRQQIKAAYL | 71 | P04083 | |
| YQRNKRNIEDALNQL | 14346 | Q8WXI7 | |
| SYRRRGKSQQQQQQQ | 486 | Q9Y618 | |
| YQQFRENVLRNLADK | 141 | Q96FI4 | |
| NDNQRYNFVLQVAKT | 791 | Q13201 | |
| QRVQYDISKSRFQRQ | 4766 | Q5CZC0 | |
| GYLARRAFQKRQQQQ | 816 | Q7Z406 | |
| NVSFINEKRYRFQNQ | 231 | Q9Y5K3 | |
| NNVFKKYQYQNRRAL | 146 | Q9BUL8 | |
| NKRYNVSQQALDLQN | 111 | Q9H1B4 | |
| LLFNKQFQYQNRIAA | 351 | P35354 | |
| QFQYQNRIAAEFNTL | 356 | P35354 | |
| QKANDENRRTYQNLV | 126 | P50748 | |
| VNRNNKQEVREANKY | 281 | P49281 | |
| NAFNNLKARARIANN | 131 | Q96PB8 | |
| QRYPRNVINNQKYNF | 51 | O75110 | |
| NVDNAQQFKQLYRAR | 191 | P30519 | |
| LQNNFREQQYKFSRQ | 281 | P23471 | |
| AADRRNVKQNQAFQY | 591 | O94886 | |
| AQNLKRNVYQNYRQF | 56 | Q8IYI6 | |
| FRQYQLSKNFEKIRN | 326 | Q9UPP2 | |
| SQAQVYELERRFKQQ | 146 | P52952 | |
| DEAKRYQEFQNRQVQ | 1026 | Q01970 | |
| NFARRQRLAQEYRKQ | 436 | Q96M91 | |
| RNANLYFLDVVQQAN | 476 | O00471 | |
| RRKLQAYQEGQQRQA | 156 | Q5TZA2 | |
| AVYIQRQFEDLNRNK | 301 | P19086 | |
| VQNKVFLRAINQYAD | 991 | Q14185 | |
| QKRAGRDDQNYNYNQ | 421 | Q6E0U4 | |
| VQQRYANVEKNSQRK | 226 | A8MYV0 | |
| IQTFKENQQCQKRYF | 316 | Q8NCU4 | |
| NRQNFINEKNIYRVP | 236 | Q13873 | |
| EKNRNSINYERQQAQ | 581 | Q13873 | |
| QYQRAALQAKRSQDL | 546 | Q5T0F9 | |
| NNHNTRNRVNGKYYE | 371 | Q5VSG8 | |
| SRKYFAQALKLNNRN | 211 | Q15006 | |
| QRYKNVLQDVNLRNF | 106 | Q9H4B8 | |
| YGRLQQDVLQFQKNQ | 131 | Q8NBJ4 | |
| QQYQSQAKQLFRKLN | 31 | O75396 | |
| LSRQNNYTVNNKRNG | 506 | P37088 | |
| DFVAKLQDNQRFRYN | 1931 | Q92736 | |
| RYAELYRRQQQQQQQ | 51 | Q5T953 | |
| RKLRSQAQSYIAQNF | 186 | Q86V97 | |
| GRAQNYQKRFQNLNW | 191 | Q9NZT2 | |
| EEKQNKFQVYQLRFQ | 1306 | O95602 | |
| DQRQKLNQEYSQQFL | 116 | Q8IZU3 | |
| KEQQSLQRFQKYFNV | 931 | Q5JRA6 | |
| NQQLSRAADYQRKSR | 221 | O15400 | |
| RNNQIRKTSYAQHQQ | 146 | P61247 | |
| RLFLQKQSQLQAYFN | 721 | Q9H0K1 | |
| KYRLFRAAQQQKQQQ | 1111 | Q9ULL8 | |
| YRELRNKANIQFGDN | 91 | Q14108 | |
| IAKRRANQQETEQFY | 436 | P0DJJ0 | |
| KLAILYRNNQFNQDE | 81 | O95379 | |
| EVLNRQNQNYKDQLS | 1136 | Q9Y2I6 | |
| QQAYRDKLAQQQAAA | 96 | Q9BZK7 | |
| VINNYQRRCKNQNTF | 56 | P10153 | |
| QALRDGYQAVVFNNR | 146 | Q96SE0 | |
| VYNVKIRFLERNQQF | 356 | Q7Z7G1 | |
| LRRFNQNQDLDTFQY | 2171 | Q63HN8 | |
| RVQFGANKNQYNLAR | 336 | Q8WVN8 | |
| ANKNQYNLARAQQSY | 341 | Q8WVN8 | |
| QGKVYNLINRRRFQQ | 1076 | Q9UKE5 | |
| TFQQRRYKCEQVFNE | 216 | Q6P9A3 | |
| FADGIKARNRNQNYL | 71 | Q9UID6 | |
| QQGQFRYNLERQQQE | 156 | Q8N443 | |
| ANRAENTERKQNQNY | 766 | Q9Y5W7 | |
| NYLQNRQFQQKQRPE | 1131 | O94759 | |
| QFLYNNNTRQQTEAR | 431 | Q15022 | |
| YKQRQAASNRRAQEL | 216 | Q9H7M9 | |
| IAKRRANQQETEQFY | 436 | O75044 | |
| ALRKNKNIDNFLNRY | 61 | O75116 | |
| NANYNLQRAFRTAEQ | 236 | Q9H254 | |
| LQNRGREAYFNLQKA | 176 | Q6PF05 | |
| ARERYLTFKALNQNN | 376 | Q9ULQ1 | |
| QNLRRAYSLQQDNCK | 116 | Q8NEE8 | |
| FTYVDKNINLEQRNR | 111 | Q96NL1 | |
| QYFQRAVKDELCRQN | 506 | Q8N584 | |
| FQIVYKSRNNSHVNR | 196 | Q9NXG2 | |
| AFQALEKLNNRQLNY | 186 | Q12792 | |
| QYQFLEDAVRNQRKL | 241 | Q13263 | |
| QNARQKARKNYENQG | 2291 | Q15911 | |
| QQQKSRAFYRIQATR | 356 | P32418 | |
| FVANRQKDNLNNYVF | 966 | Q12879 | |
| RVRENQKNFSLLQYQ | 6106 | P20929 |